Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jan 6;12(2):455.
doi: 10.3390/jcm12020455.

What Is New in the Management of High-Risk Localized Prostate Cancer?

Mudassir Wani  1 , Sanjeev Madaan  2   3
Affiliations
Editorial

What Is New in the Management of High-Risk Localized Prostate Cancer?

Mudassir Wani et al. J Clin Med. .

Abstract

The current Special Issue, in the Journal of Clinical Medicine, is dedicated to collecting high-quality research that mainly focuses on "Clinical advances in Prostate Cancer Treatments" [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Giona S. Prostate Cancer. Exon Publications; Brisbane, Australia: 2021. [(accessed on 19 November 2022)]. The Epidemiology of Prostate Cancer. Available online: https://www.ncbi.nlm.nih.gov/books/NBK571326/ - PubMed
    1. D’Amico A.V. Biochemical Outcome after Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer. JAMA. 1998;280:969. doi: 10.1001/jama.280.11.969. - DOI - PubMed
    1. Rosoff J.S., Savage S.J., Prasad S.M. Salvage Radical Prostatectomy as Management of Locally Recurrent Prostate Cancer: Outcomes and Complications. World J. Urol. 2013;31:1347–1352. doi: 10.1007/s00345-013-1029-z. - DOI - PubMed
    1. Wang X., Sun R., Wang J., Li J., Walker E., Shirke A., Ramamurthy G., Shan L., Luo D., Carmon L., et al. A Low Molecular Weight Multifunctional Theranostic Molecule for the Treatment of Prostate Cancer. Theranostics. 2022;12:2335–2350. doi: 10.7150/thno.68715. - DOI - PMC - PubMed

Publication types

LinkOut - more resources